| 1 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
CREBBP |
| 2 |
34601504 |
10.1038/s41379-021-00938-z |
2022 |
Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. |
CREBBP |
| 3 |
34664256 |
10.1111/bjh.17894 |
2022 |
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA. |
CREBBP |
| 4 |
34837284 |
10.1111/cas.15224 |
2022 |
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. |
CREBBP |
| 5 |
34957565 |
10.1002/path.5861 |
2022 |
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma. |
CREBBP |
| 6 |
34967008 |
10.1111/bjh.17990 |
2022 |
The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. |
CREBBP |
| 7 |
34977845 |
10.1016/j.xjidi.2021.100068 |
2022 |
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders. |
CREBBP |
| 8 |
35022084 |
10.1186/s13046-021-02234-9 |
2022 |
The follicular lymphoma epigenome regulates its microenvironment. |
CREBBP |
| 9 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
CREBBP |
| 10 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
CREBBP |
| 11 |
35205765 |
10.3390/cancers14041018 |
2022 |
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. |
CREBBP |
| 12 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
CREBBP |
| 13 |
35255429 |
10.1016/j.anndiagpath.2021.151886 |
2022 |
De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients. |
CREBBP |
| 14 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
CREBBP |
| 15 |
35363872 |
10.1182/bloodadvances.2021005284 |
2022 |
Molecular subclusters of follicular lymphoma: a report from the UK's Haematological Malignancy Research Network. |
CREBBP |
| 16 |
35401516 |
10.3389/fimmu.2022.842439 |
2022 |
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. |
CREBBP |
| 17 |
35454811 |
10.3390/cancers14081904 |
2022 |
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. |
CREBBP |
| 18 |
35734168 |
10.3389/fimmu.2022.922471 |
2022 |
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. |
CREBBP |
| 19 |
35816682 |
10.1182/bloodadvances.2022008355 |
2022 |
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared to stage III/IV. |
CREBBP |
| 20 |
35908982 |
10.1016/j.blre.2022.100992 |
2022 |
Follicular lymphoma: The long and winding road leading to your cure? |
CREBBP |
| 21 |
35964234 |
10.1093/ajcp/aqac087 |
2022 |
Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma. |
CREBBP |
| 22 |
32855278 |
10.3324/haematol.2020.254854 |
2021 |
Genetic evolution of <i>in situ</i> follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype. |
CREBBP |
| 23 |
32929178 |
10.1038/s41379-020-00673-x |
2021 |
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. |
CREBBP |
| 24 |
32973328 |
10.1038/s41379-020-00685-7 |
2021 |
The clinicopathological and molecular features of sinusoidal large B-cell lymphoma. |
CREBBP |
| 25 |
33311649 |
10.1038/s41379-020-00720-7 |
2021 |
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. |
CREBBP |
| 26 |
33413063 |
10.2174/1568009620666210106122750 |
2021 |
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL). |
CREBBP |
| 27 |
33431788 |
10.1038/s41392-020-00437-8 |
2021 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
CREBBP |
| 28 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
CREBBP |
| 29 |
33560380 |
10.1182/bloodadvances.2020002469 |
2021 |
Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. |
CREBBP |
| 30 |
33562694 |
10.3390/cancers13040641 |
2021 |
Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. |
CREBBP |
| 31 |
33747936 |
10.3389/fonc.2021.622648 |
2021 |
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. |
CREBBP |
| 32 |
33777766 |
10.3389/fonc.2021.620435 |
2021 |
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. |
CREBBP |
| 33 |
33829512 |
10.1111/his.14378 |
2021 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
CREBBP |
| 34 |
33911074 |
10.1038/s41419-021-03695-8 |
2021 |
Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma. |
CREBBP |
| 35 |
33945543 |
10.1371/journal.pone.0248886 |
2021 |
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. |
CREBBP |
| 36 |
33959502 |
10.3389/fonc.2021.638897 |
2021 |
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study. |
CREBBP |
| 37 |
34334687 |
10.1097/PAS.0000000000001726 |
2021 |
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B. |
CREBBP |
| 38 |
34481935 |
10.1016/j.canlet.2021.09.002 |
2021 |
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma. |
CREBBP |
| 39 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
CREBBP |
| 40 |
34671837 |
10.1007/s00292-021-01011-x |
2021 |
[Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma]. |
CREBBP |
| 41 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
CREBBP |
| 42 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
CREBBP |
| 43 |
35071240 |
10.3389/fcell.2021.805195 |
2021 |
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies. |
CREBBP |
| 44 |
35528192 |
10.1158/2767-9764.crc-21-0022 |
2021 |
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. |
CREBBP |
| 45 |
31423576 |
10.1111/bjh.16159 |
2020 |
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. |
CREBBP |
| 46 |
31752573 |
10.1080/10428194.2019.1691200 |
2020 |
New murine models of aggressive lymphoma. |
CREBBP |
| 47 |
31774495 |
10.1182/blood.2019001904 |
2020 |
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. |
CREBBP |
| 48 |
31807922 |
10.1007/s00428-019-02691-w |
2020 |
Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. |
CREBBP |
| 49 |
31915197 |
10.1158/2159-8290.CD-19-0116 |
2020 |
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. |
CREBBP |
| 50 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
CREBBP |
| 51 |
32316399 |
10.3390/cancers12040986 |
2020 |
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing. |
CREBBP |
| 52 |
32459397 |
10.1111/jcmm.15425 |
2020 |
Establishment and characterization of a novel 'double-hit' follicular lymphoma cell line, FL-SJC. |
CREBBP |
| 53 |
32546039 |
10.1080/10428194.2020.1775216 |
2020 |
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma. |
CREBBP |
| 54 |
32555149 |
10.1038/s41408-020-0335-0 |
2020 |
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. |
CREBBP |
| 55 |
32576962 |
10.1038/s41375-020-0908-8 |
2020 |
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas. |
CREBBP |
| 56 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
CREBBP |
| 57 |
33097085 |
10.1186/s13148-020-00948-9 |
2020 |
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma. |
CREBBP |
| 58 |
33160401 |
10.1186/s13148-020-00962-x |
2020 |
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma. |
CREBBP |
| 59 |
33188997 |
10.1016/j.ctarc.2020.100235 |
2020 |
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. |
CREBBP |
| 60 |
33211828 |
10.1182/bloodadvances.2020002944 |
2020 |
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. |
CREBBP |
| 61 |
30213827 |
10.3324/haematol.2018.203224 |
2019 |
<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. |
CREBBP |
| 62 |
30307363 |
10.1080/15384047.2018.1523857 |
2019 |
Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL). |
CREBBP |
| 63 |
30348636 |
10.1158/1078-0432.CCR-18-1153 |
2019 |
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. |
CREBBP |
| 64 |
30446494 |
10.1182/blood-2018-07-865428 |
2019 |
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016. |
CREBBP |
| 65 |
30567752 |
10.1182/blood-2018-07-864025 |
2019 |
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. |
CREBBP |
| 66 |
30632835 |
10.1080/10428194.2018.1516878 |
2019 |
Descriptive analysis of genetic aberrations and cell of origin in Richter transformation. |
CREBBP |
| 67 |
30979734 |
10.1158/1078-0432.CCR-18-3989 |
2019 |
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas. |
CREBBP |
| 68 |
31182547 |
10.1158/0008-5472.CAN-18-3622 |
2019 |
CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms. |
CREBBP |
| 69 |
31221981 |
10.1038/s12276-019-0230-6 |
2019 |
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. |
CREBBP |
| 70 |
31366566 |
10.1042/BSR20191162 |
2019 |
Genetic polymorphism and transcriptional regulation of <i>CREBBP</i> gene in patient with diffuse large B-cell lymphoma. |
CREBBP |
| 71 |
31403034 |
10.3389/fonc.2019.00683 |
2019 |
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. |
CREBBP |
| 72 |
31475375 |
10.1002/hon.2674 |
2019 |
m7FLIPI and targeted sequencing in high-risk follicular lymphoma. |
CREBBP |
| 73 |
31489524 |
10.1007/s11899-019-00541-9 |
2019 |
Chromatin-Remodeled State in Lymphoma. |
CREBBP |
| 74 |
31519498 |
10.1016/j.immuni.2019.08.006 |
2019 |
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma. |
CREBBP |
| 75 |
31533053 |
10.1016/j.immuni.2019.08.018 |
2019 |
Scoring a HAT-Trick against Lymphoma. |
CREBBP |
| 76 |
31669559 |
10.1016/j.exphem.2019.10.004 |
2019 |
Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies. |
CREBBP |
| 77 |
29158360 |
10.1182/blood-2017-08-737361 |
2018 |
Chromatin modifying gene mutations in follicular lymphoma. |
CREBBP |
| 78 |
29193015 |
10.1111/bjh.15041 |
2018 |
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion. |
CREBBP |
| 79 |
29305415 |
10.3324/haematol.2017.182444 |
2018 |
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. |
CREBBP |
| 80 |
29359884 |
10.1002/ajmg.a.38603 |
2018 |
Benign and malignant tumors in Rubinstein-Taybi syndrome. |
CREBBP |
| 81 |
29452662 |
10.1016/j.beha.2017.10.006 |
2018 |
Pathogenesis of follicular lymphoma. |
CREBBP |
| 82 |
29884215 |
10.1186/s13072-018-0197-x |
2018 |
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation. |
CREBBP |
| 83 |
29895903 |
10.1038/s41408-018-0089-0 |
2018 |
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. |
CREBBP |
| 84 |
29989027 |
10.18632/oncotarget.25601 |
2018 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. |
CREBBP |
| 85 |
30126979 |
10.1182/blood-2018-03-837252 |
2018 |
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. |
CREBBP |
| 86 |
30227405 |
10.1159/000491013 |
2018 |
Microarray-Based Gene Expression Analysis Identifies Potential Diagnostic and Prognostic Biomarkers for Waldenström Macroglobulinemia. |
CREBBP |
| 87 |
30274972 |
10.1158/2159-8290.CD-18-0657 |
2018 |
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. |
CREBBP |
| 88 |
30360879 |
10.1053/j.seminoncol.2018.07.005 |
2018 |
New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. |
CREBBP |
| 89 |
27389057 |
10.1038/leu.2016.175 |
2017 |
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. |
CREBBP |
| 90 |
27733359 |
10.1158/2159-8290.CD-16-0975 |
2017 |
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. |
CREBBP |
| 91 |
27742770 |
10.3324/haematol.2016.144964 |
2017 |
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. |
CREBBP |
| 92 |
28062671 |
10.1158/2159-8290.CD-16-1285 |
2017 |
Targeting HDAC3 in CREBBP-Mutant Lymphomas Counterstrikes Unopposed Enhancer Deacetylation of B-cell Signaling and Immune Response Genes. |
CREBBP |
| 93 |
28064239 |
10.1182/blood-2016-07-729954 |
2017 |
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. |
CREBBP |
| 94 |
28069569 |
10.1158/2159-8290.CD-16-1417 |
2017 |
The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma. |
CREBBP |
| 95 |
28106467 |
10.1080/15592294.2017.1282587 |
2017 |
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations. |
CREBBP |
| 96 |
28116089 |
10.1186/s40425-016-0207-0 |
2017 |
It's a long way to the top (if you want to personalize immunotherapy). |
CREBBP |
| 97 |
28152507 |
10.18632/oncotarget.14928 |
2017 |
The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. |
CREBBP |
| 98 |
28288979 |
10.1182/blood-2016-08-733469 |
2017 |
<i>Crebbp</i> loss cooperates with <i>Bcl2</i> overexpression to promote lymphoma in mice. |
CREBBP |
| 99 |
28302137 |
10.1186/s13045-017-0438-7 |
2017 |
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort. |
CREBBP |
| 100 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
CREBBP |
Datasets
Models
